Connection
Robert MacLaren to Factor Xa Inhibitors
This is a "connection" page, showing publications Robert MacLaren has written about Factor Xa Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.323 |
|
|
|
-
Buckley MS, Benanti GE, Gilbert B, Meckel J, Dzierba AL, MacLaren R. Correlation between heparin anti-Xa activity and thromboelastography in adult critically ill COVID-19 patients. Pharmacotherapy. 2023 08; 43(8):795-803.
Score: 0.187
-
Van Matre ET, Reynolds PM, MacLaren R, Mueller SW, Wright GC, Moss M, Burnham EL, Ho PM, Vandivier RW, Kiser TH. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer. J Thromb Haemost. 2018 12; 16(12):2492-2500.
Score: 0.136